Atlas Trials

Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis

Clinical trial NCT02866721 · COMPLETED

Trial details

NCT number
NCT02866721
Sponsor
University Hospitals Cleveland Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2016-08-01
Primary completion
2020-08-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.